Literature DB >> 31539643

Approaching spinal metastases spread profile.

Aymeric Amelot1, Louis-Marie Terrier2, Joseph Cristini3, Louis-Romée LeNail4, Kévin Buffenoir3, Hugues Pascal-Moussellard5, Raphael Bonaccorsi5, Bertrand Mathon6.   

Abstract

BACKGROUND: Spinal metastases cause significant morbidity. The vertebral column is the most common site of cancer metastasis, however predilection of metastases for the spine is not fully understood.
OBJECTIVE: The aim of the present investigation was to obtain a better description of the distribution of spinal metastases. The main objective of our study was to figure out how malignant cells disseminate within the spine and determine a potent mapping or profile of the metastatic spread routes. STUDY
DESIGN: A prospective French national multicenter database.
METHODS: 740 consecutive patients were treated for spine metastasis (SpM) between January 2014 and 2017. A categorisation of the anatomical distribution of spine lesions was conducted.
RESULTS: One hundred and seventy patients (22.9% of series) presented cervical SpM, 440 (60%) lumbar SpM, and a majority 530 (71.6%) at the thoracic vertebral level. Metastases were more often present in the vertebral body (645 patients, 87.2%) than in a posterior location (278 patients, 37.6%, p < 0.0001). 212/740 patients (28.6%) presented circumferential spine involvement (body and posterior elements). An associated epiduritis was presented in 404 patients (54.6%). Primitive neck tumors spread towards the cervical spine: ENT (34.8%, p = 0.049), thyroid (33.3%, p = 0.043) whereas pelvic tumors targeted the lumbar spine: prostate (72%, p = 0.011), bladder (75%, p = 0.047). All tumors presented a tropism for thoracic vertebrae. Significant tumor/vertebrae associations were identified: lung (p = 0.004) and thyroid (p = 0.028) for L1, bladder for L5 (p = 0.0025), breast for C6 (p = 0.006), Prostate for L1-L4 (p = 0.002-0.04), multiple myelomas for C7, p = 0.03, T3-T7 (p < 0.0001-0.025) and L1-L4 (p = 0.004-0.027). Spine was the latest organ affected by metastases with a median-free survival of 4.2 months (SD 1.8, p = 0.001).
CONCLUSIONS: Although we determined that some tumors have a significant propensity to localise at certain vertebral level, it remains premature to conclude on a spinal metastases profile. To date, it is too early to provide recommendations in imaging follow-up or in preventive therapeutic based on this mapping of spine metastases.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Epiduritis; Metastatic spreading; Spine metastases; Survival; Vertebrae

Mesh:

Year:  2019        PMID: 31539643     DOI: 10.1016/j.suronc.2019.08.007

Source DB:  PubMed          Journal:  Surg Oncol        ISSN: 0960-7404            Impact factor:   3.279


  7 in total

1.  The effects of combined microwave ablation and open surgery for the treatment of lung cancer-derived thoracolumbar metastases.

Authors:  Guoqing Zhong; Longhui Zeng; Yue He; Xiaolong Zeng; Wenhan Huang; Tao Yang; Xiao Chu; Jin Xiao; Dong Yin; Yunbing Chang; Shi Cheng; Yu Zhang
Journal:  Orthop Surg       Date:  2022-05-23       Impact factor: 2.279

2.  Treatment of cervical spine metastasis with minimally invasive cervical spondylectomy: A case report and literature review.

Authors:  Li-Ming He; Xun Ma; Chen Chen; Hong-Yi Zhang
Journal:  World J Clin Cases       Date:  2021-01-26       Impact factor: 1.337

3.  Validity of negative bone biopsy in suspicious bone lesions.

Authors:  Mine B Lange; Lars J Petersen; Michael B Nielsen; Helle D Zacho
Journal:  Acta Radiol Open       Date:  2021-07-27

Review 4.  Ten Years After SINS: Role of Surgery and Radiotherapy in the Management of Patients With Vertebral Metastases.

Authors:  Nicolas Serratrice; Joe Faddoul; Bilal Tarabay; Christian Attieh; Moussa A Chalah; Samar S Ayache; Georges N Abi Lahoud
Journal:  Front Oncol       Date:  2022-01-27       Impact factor: 6.244

5.  Clinical utility of convolutional neural networks for treatment planning in radiotherapy for spinal metastases.

Authors:  Sebastiaan R S Arends; Mark H F Savenije; Wietse S C Eppinga; Joanne M van der Velden; Cornelis A T van den Berg; Joost J C Verhoeff
Journal:  Phys Imaging Radiat Oncol       Date:  2022-02-17

Review 6.  Biological and Clinical Aspects of Metastatic Spinal Tumors.

Authors:  Jakub Litak; Wojciech Czyżewski; Michał Szymoniuk; Leon Sakwa; Barbara Pasierb; Joanna Litak; Zofia Hoffman; Piotr Kamieniak; Jacek Roliński
Journal:  Cancers (Basel)       Date:  2022-09-22       Impact factor: 6.575

7.  Survival after surgery for spinal metastatic disease: a nationwide multiregistry cohort study.

Authors:  Christian Carrwik; Claes Olerud; Yohan Robinson
Journal:  BMJ Open       Date:  2021-11-01       Impact factor: 2.692

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.